Voting results along with the Scrutinizer report.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bharat Parenterals Ltd held its 32nd AGM on September 26, 2025 via video conferencing (11:00 AM to 11:50 AM), and all 9 resolutions were passed with overwhelming majority. Key approvals included adoption of FY25 audited financial statements (including consolidated), declaration of a final dividend for FY ended March 31, 2025, appointment of Shah Mehta & Bakshi as statutory auditors, appointment of Jigar Trivedi & Co. as secretarial auditors for 5 years, ratification of cost auditor (CMA Chetan Gandhi) remuneration, regularisation of Mr. Alkesh Jayantilal Shah as Non-Executive Director, re-appointment of Mr. Hemang J Shah (retiring by rotation), re-appointment of Mr. Mukeshbhai Jivrajbhai Patel as Independent Director for 5 years (Sept 2025 to Sept 2030), and approval of related party transactions. Voting was conducted through remote e-voting and e-voting at the AGM, with total votes polled of 46,86,918 shares (68.01% of paid-up capital); votes in favour were 99.98% (only 708 votes against).
Routine, broadly positive outcome for shareholders: the final dividend declaration means an income event for eligible shareholders, while clean approvals of director and auditor appointments, plus RPT clearance, support business continuity and signal stable governance. The near-unanimous vote strength suggests no meaningful shareholder dissent.